| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/13/2010 | US7754857 Human p51 genes and gene products thereof |
| 07/13/2010 | US7754856 Human sodium-dependent bile acid transporter proteins |
| 07/13/2010 | US7754734 Administering one or more rapamycin derivatives (including rapamycin and 40-O-(2-hydroxy)ethyl-rapamycin); lymphocytic leukemia, lymphoma, Epstein-Barr virus, inhibiting graft rejection and metastasis; drug screening |
| 07/13/2010 | US7754500 combined with bioactive agents for a variety of purposes including drug delivery and conjugation to one member of a binding pair for use in an assay |
| 07/13/2010 | US7754499 Semi-continuous blood separation using magnetic beads |
| 07/13/2010 | US7754498 Self-encoding sensor with microspheres |
| 07/13/2010 | US7754497 Method for immobilizing proteins |
| 07/13/2010 | US7754496 Determination of free fractions |
| 07/13/2010 | US7754495 Methods for early diagnosing of an increased risk of preeclampsia |
| 07/13/2010 | US7754494 comprises a syringe housed in a sterile enclosure made of two parts, and allows the syringe to be operated while it is in the enclosure; plunger in the syringe can be operated repeatedly without compromising sterility |
| 07/13/2010 | US7754493 Method for measuring surface plasmon resonance |
| 07/13/2010 | US7754492 Thermal sensing device |
| 07/13/2010 | US7754491 Sensor for measuring syngas ratios under high temperature and pressure conditions |
| 07/13/2010 | US7754490 analyzing a multi-constituent fluid sample such as urine and serum for high concentration analytes; laminar fluid diffusion interface |
| 07/13/2010 | US7754489 using a hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters; protocols for monitoring the efficacy of patient hemostasis therapies |
| 07/13/2010 | US7754488 testing the quality or the identity of a functional fluid (lubricating fluids and fuels like those used in automobiles, trucks, engines, turbines, pumps, transmissions, differentials ) in the field rapidly by untrained personnel and without precision measurement; reacting the fluid with an indicator |
| 07/13/2010 | US7754487 Hematology linearity control composition, system and method of use |
| 07/13/2010 | US7754480 composition consisting of a population of cells having retained therein a detectable product resulting from conversion by the cell of BODIPY aminoacetaldehyde to the detectable product BODIPY aminoacetate |
| 07/13/2010 | US7754472 comprises one or more reaction chambers and/or one or more reagent application channels, capillary systems and negative vessels; haemagglutination |
| 07/13/2010 | US7754466 Method for producing dipeptides |
| 07/13/2010 | US7754459 having an amino acid sequence which has a functional NAD+ binding domain and no PARP zinc finger sequence motifs |
| 07/13/2010 | US7754453 Identifying polymerase chain reaction primer extension products using fluorescence energy transfer (FET); detecting allelic variation/restriction fragment length polymorphisms |
| 07/13/2010 | US7754442 Reagent kit for determining characteristic of tissue |
| 07/13/2010 | US7754441 patient selection for treatment of B cell lymphoma; treatment with an antibody conjugated to a growth-inhibitory agent or a cytotoxic agent |
| 07/13/2010 | US7754440 Disposing cell comprising sodium channel blocker into a well, disposing fluorescent dye into well; adding sodium channel blocker, to be identified, into well; passing stimulating current to generate an action potential; optically measuring |
| 07/13/2010 | US7754439 Method and system for the analysis of high density cells samples |
| 07/13/2010 | US7754438 Solid state NMR method for screening cell membrane protein binding drug candidates |
| 07/13/2010 | US7754437 Qualitatively and quantitatively detection where the transketolase 1(TKTL1) protein is used as indicator and target molecule by determining the activity and/or concentration, cellular localization, aggregation status and/or dimerization status; inhibitors/activators controllers;nervous system disorders |
| 07/13/2010 | US7754436 by use of Heart and brain fatty acid binding proteins (H-FABP, B-FABP) are markers |
| 07/13/2010 | US7754435 Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms |
| 07/13/2010 | US7754434 by measuring the concentration of a brain-derived neurotrophic factor in blood of the patients; anorexia and bulimia nervosa |
| 07/13/2010 | US7754433 Identification of high affinity molecules by limited dilution screening |
| 07/13/2010 | US7754432 Using mobility shift binding bioassays for analyzing interactions between heparan sulfate derivatives and binding partners such as fibroblast growth factors and antithrombin; coagulants; antitumor/antiproliferative agents |
| 07/13/2010 | US7754431 selecting a taxane or taxane derivative for chemotherapy of the cancer patient when the TLE3 (transducin-like enhancer of split 3) expression is present; paclitaxel; docetaxel |
| 07/13/2010 | US7754425 Process for aligning macromolecules by passage of a meniscus and applications |
| 07/13/2010 | US7754419 Determination of testosterone by mass spectrometry |
| 07/13/2010 | US7754418 Immunoglobulin composition for detection of cell death regulatory proteins; diagnosing cardiovascular, tumor, diabetic and nervous system disorders |
| 07/13/2010 | US7754273 printing onto the substrate at least one time temperature indicator with chromic properties based on an azo coupling reaction between a capped diazonium component and a coupling component |
| 07/13/2010 | US7754245 Solid bio-material for a sensor that detects bio-electric signals through the use of the characteristics and functions of bio-epidermal tissues and epidermal tissues of living organisms and the methods for producing the same |
| 07/13/2010 | US7754228 Cytotoxic T-cell epitopes from Chlamydia |
| 07/13/2010 | US7754224 Nucleotide sequences coding glycoprotein for use in vaccine development for prevention of ehrichlia infection; serodiagnostic agents |
| 07/13/2010 | US7754221 A recombinant Lister vaccinia virus, comprising a modified thymidine kinase gene, a modified hemagglutinin gene, and a modified F3gene or locus, each gene or locus is denactivated; the virus comprises heterologous nucleic acid encoding a gene; antitumor,carcinogenic, -proliferative agents; nontoxic |
| 07/13/2010 | US7754220 Continuously administering to a male animal a polypeptide havingan amino acid sequence to promote the activity of Metastin, (kisspeptin-54), an endogenous ligand for G protein-coupled receptor; promoters of fertility, ovulation; treating hormone-sensitive cancers; endometriosis; drug screening |
| 07/13/2010 | US7754219 by binding a target antigen (such as a protein) to a transport factor that contains a fragment of a bipartite protein exotoxin, but not the corresponding protective antigen |
| 07/13/2010 | US7754216 treating inflammatory conditions by modulating kallikrein 6 protease activity |
| 07/13/2010 | US7754214 Using DCRS5 cytokine receptors modulators to treat psoriasis and atopic dermatitis |
| 07/13/2010 | US7754206 reducing the size of a solid tumor expressing CD44 using Notch4 antagonist |
| 07/13/2010 | US7754155 Apparatus comprising avidin/streptavidin substrate for recovering and identifying cells which are adhered to by biotin conjugated antibodies |
| 07/13/2010 | US7754150 Use of a component-binding moiety specific to the component of interest, such as an antibody, to detect the component of interest |
| 07/13/2010 | US7754145 Fluorphore embedded/incorporating/bridged periodic mesoporous organosilicas as recognition photo-decontamination catalysts |
| 07/13/2010 | US7754093 Electrodes on support; mediator is 1,10-phenanthroline-5,6-dione; for detecting an analyte in a sample; accurate clinical response |
| 07/13/2010 | US7754059 An electrical measuring detector determining the concentrationof an analyte in a biological sample; a silicon nonionic surfactantcoats the mesh layer between the electrodes and covering layer; improved properties over fluorinated surfactants; stability; uniformity; nontoxic, abhesion |
| 07/13/2010 | US7752893 In-situ analysis method and system |
| 07/13/2010 | US7752883 Tribometer |
| 07/13/2010 | CA2502395C Measurement device for determining oxygen activity in metal or slag melts |
| 07/13/2010 | CA2469804C Method for measuring adsorbed and interstitial fluids |
| 07/13/2010 | CA2452891C Sensor device for detection of dissolved hydrocarbon gases in oil filled high-voltage electrical equipment |
| 07/13/2010 | CA2433096C Methods for the treatment of ibs |
| 07/13/2010 | CA2430035C Method and device for continuously treating waste water of industrial origin by water vapour stripping |
| 07/13/2010 | CA2381439C Single-chain polypeptides comprising troponin i n-terminal fragments and troponin c |
| 07/13/2010 | CA2372175C Immobilized enzymes as biosensors for chemical toxins |
| 07/13/2010 | CA2356533C Inhibitors of the bitter taste response |
| 07/13/2010 | CA2345932C Peptide-based carrier devices for stellate cells |
| 07/13/2010 | CA2344145C Inventory control |
| 07/13/2010 | CA2316280C Novel g protein-coupled receptor |
| 07/13/2010 | CA2302791C Method and device for identifying active substances |
| 07/13/2010 | CA2271449C Diagnosis of feline immunodeficiency virus infection using env/gag polypeptide markers |
| 07/13/2010 | CA2262893C Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins |
| 07/13/2010 | CA2259724C Monoclonal antibody which is specific for activated coagulation factor vii, and its use |
| 07/13/2010 | CA2252983C Method for determining the anticoagulatory potential of a sample |
| 07/13/2010 | CA2245242C Purified sr-p70 protein |
| 07/13/2010 | CA2190374C Optical method and apparatus for the diagnosis of cervical precancers using raman and fluorescence spectroscopies |
| 07/13/2010 | CA2183589C Method of assaying normal aggrecan, assaying kit, and method of judging joint-related information |
| 07/13/2010 | CA2183564C Methods for altering fertility |
| 07/12/2010 | CA2689830A1 Method to inhibit scale formation in cooling circuits using carbon dioxide |
| 07/08/2010 | WO2010078555A2 Capacitive and resistive conductivity engine oil analyzer |
| 07/08/2010 | WO2010078554A1 Process design using mass spectrometry |
| 07/08/2010 | WO2010078531A2 Uses of bortezomib in predicting survival in multiple myeloma patients |
| 07/08/2010 | WO2010078518A1 Anti-herpes simplex virus antibodies and methods of use thereof |
| 07/08/2010 | WO2010078515A2 Polymer end group detection |
| 07/08/2010 | WO2010078514A2 Quantification of non-reducing end glycan residual compounds |
| 07/08/2010 | WO2010078511A2 Detection of oligosaccharides |
| 07/08/2010 | WO2010078482A1 Live bioload detection using microparticles |
| 07/08/2010 | WO2010078465A2 Capillary flow solid phase assay |
| 07/08/2010 | WO2010078443A1 Method and device for immunoassay using nucleotide conjugates |
| 07/08/2010 | WO2010078420A2 Systems, devices, methods and kits for fluid handling |
| 07/08/2010 | WO2010078411A1 Method of predicting acute appendicitis |
| 07/08/2010 | WO2010078404A1 Methods, kits and systems for processing samples |
| 07/08/2010 | WO2010078403A2 Methods and compositions for diagnosing urological disorders |
| 07/08/2010 | WO2010078379A2 Catalytically-generated gas in hydrocarbon bearing source rocks |
| 07/08/2010 | WO2010078376A2 Fc-specific polymer-conjugated antibodies and their diagnostic use |
| 07/08/2010 | WO2010078290A2 System for screening agonists/antagonists of cellular signaling pathways |
| 07/08/2010 | WO2010078262A1 Compositions and methods for eluting compounds from matrices |
| 07/08/2010 | WO2010078194A1 Method for screening blood using a preservative that may be in a substantially solid state form |
| 07/08/2010 | WO2010078147A2 Fecal examination receptacle |
| 07/08/2010 | WO2010077921A1 Prostate cancer markers and uses thereof |
| 07/08/2010 | WO2010077870A2 Stable compositions comprising chromogenic compounds and methods of use |
| 07/08/2010 | WO2010077767A1 Oxygen monitoring system and method for determining an oxygen density load of a fluid |
| 07/08/2010 | WO2010077765A1 Treatment system and method for removing challenge materials from a water stream |
| 07/08/2010 | WO2010077754A1 Optically active functional fluid markers |